Vai al contenuto principale della pagina

EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY) Visualizza cluster
Pubblicazione: Washington : , : U.S. Government Publishing Office, , 2018
Descrizione fisica: 1 online resource (iii, 43 pages) : illustrations
Soggetto topico: Prescription pricing - United States
Drugs - Law and legislation - United States
Pharmaceutical industry - United States
Competition - United States
Drug delivery devices - Prices - United States
Soggetto genere / forma: Legislative hearings.
Nota di bibliografia: Includes bibliographical references.
Altri titoli varianti: EpiPen price increases
Titolo autorizzato: EpiPen price increases  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910711623503321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui